Aerie Pharmaceuticals

Aerie Pharmaceuticals

A pharmaceutical company focused on developing products for the treatment of glaucoma

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

March 7, 2011

Aerie Pharmaceuticals raises a $41,364,965 series B round from Clarus Ventures, Alta Partners and Osage University Partners.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
BioSpace
June 11, 2020
BioSpace
Aerie Pharmaceuticals, Inc. announced that Peter J. McDonnell, M.D., has been appointed to the Company's Board of Directors and will also be a member of both the Nominating and Corporate Governance and Compensation Committees of the Board.
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.